Samples of the first recurrence (n=38, median expression 3,45 NE IQR 1.89-5.76 NE) showed a decreased median expression of PD-L1 of 54.04% in comparison to de-novo GBM (Figure 2A). The gene discussed is CD274; the disease is glioblastoma.